Genital warts are growths caused by HPV (most often types 6 and 11). There is no cure for the virus, but several topical and provider-applied treatments remove or reduce visible warts. The HPV vaccine prevents the HPV types that cause most genital warts. Condoms reduce but do not eliminate transmission risk. Regular healthcare, honest partner communication, and vaccination offer practical paths to prevention and management.

What genital warts are

Genital warts are small growths caused by certain strains of the human papillomavirus (HPV), most commonly types 6 and 11. They can appear on the genitals, around the anus, and sometimes in the mouth or throat after oral contact. The warts themselves can be embarrassing and uncomfortable, but they are not the same HPV types that typically cause cancers.

Virus vs. visible warts

There is no cure that eradicates HPV from the body. Medical treatments remove or reduce visible warts and control outbreaks, but the underlying virus can persist. Many people never develop visible warts even while carrying HPV, and in many cases the immune system clears the infection over time.

Proven treatment options

Treatment choices focus on removing lesions and managing symptoms. Options include:

  • Patient-applied topicals: podofilox (0.5% solution or gel), imiquimod cream (5% or 3.75%), and sinecatechins ointment (15%) for external genital and perianal warts.
  • Provider-applied therapies: cryotherapy (freezing), trichloroacetic acid (chemical cautery), surgical excision, or electrosurgery.
These approaches reduce or eliminate visible warts. Recurrences can happen, and some people require repeated treatment. There are no routinely recommended oral medications that cure HPV.

Transmission and prevention

HPV spreads primarily through skin-to-skin sexual contact, including genital and oral sex. Condoms lower the risk but do not provide complete protection because they may not cover all affected skin. Open communication with partners and regular sexual health care are important.

The HPV vaccine (currently available as a nine-valent vaccine) prevents infection with the HPV types that cause most genital warts and many cancers. Vaccination is most effective before first sexual exposure, and public health guidance supports routine vaccination in adolescence with catch-up and shared decision-making recommendations for some adults.

Living with HPV and genital warts

Although genital warts can be distressing, treatments make it possible to manage outbreaks and live normally. Doctors can remove visible lesions and advise on monitoring and prevention. If you have symptoms, see a healthcare provider for diagnosis, treatment options, and counseling about vaccination and partner notification.

FAQs about Genital Warts Medication

Are genital warts curable?
The virus that causes genital warts (HPV) cannot be reliably cured, but visible warts can be removed or reduced with treatments. The infection may still persist and recurrences are possible.
What treatments work for genital warts?
Effective treatments include patient-applied creams such as podofilox and imiquimod, sinecatechins ointment, and provider-applied procedures like cryotherapy, trichloroacetic acid, surgical removal, or electrosurgery. Choice depends on wart location, size, and patient preference.
Can the HPV vaccine prevent genital warts?
Yes. The current nine-valent HPV vaccine protects against the HPV types responsible for most genital warts and reduces the risk of future wart formation when given before exposure.
How can I reduce the chance of spreading genital warts?
Use condoms to lower transmission risk, avoid sexual contact while warts are present, and discuss vaccination and testing with partners. Seeking prompt treatment for visible warts also helps reduce spread.
Should I tell my sexual partners if I have genital warts?
Yes. Honest communication allows partners to seek evaluation, consider vaccination if appropriate, and make informed decisions about sexual activity and protection.

News about Genital Warts Medication

Genital Warts Market Size to Reach USD 1,435.0 Million by 2035, Impelled by Advancements in Gene Therapy and Personalized Medicine - BioSpace [Visit Site | Read More]

How to Treat Warts at Home and in the Clinic - University of Utah Health [Visit Site | Read More]

(PDF) Position statement for the diagnosis and management of anogenital warts - researchgate.net [Visit Site | Read More]

Is It Herpes or Something Else? How To Tell - health.com [Visit Site | Read More]

Development of Seborrheic Keratosis and Human Papillomavirus (HPV) Infection Following Four Months of Fingolimod Treatment in a Patient With Multiple Sclerosis: A Report of a Rare Case - Cureus [Visit Site | Read More]

Genital Warts Treatment Market Growth Analysis | CAGR of 4.9% - Market.us Media [Visit Site | Read More]

Cancer Interception: The First HPV Antiviral Treatment Fights Pre-Cancers - UNM HSC Newsroom [Visit Site | Read More]